1. Market Research
  2. > Biotechnology Market Trends
  3. > Viral Clearance Market by Application, Method, Detection & End User - Global Forecast to 2020

The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020. The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015. The increasing number of drug approvals will boost the viral clearance market.

This report segments the global viral clearance market is segmented based on method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method. The viral detection method is further subsegmented in to plaque assays, PCR, ELISA, and other viral detection method. Other viral detection method includes western blot, transmission EM, in vivo assay, in vitro assay, and NGS (Next Generation Sequencing). The viral removal method is further subsegmented in to chromatography, nanofiltration, and precipitation. The viral inactivation method is further subsegmented in to solvent detergent method, pasteurization, and other viral inactivation method. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). North America is further divided into Canada and the U.S.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the viral clearance market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of top players in the viral clearance market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the viral clearance market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the viral clearance market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various viral clearance products across geographies
- Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the viral clearance market

Table Of Contents

Viral Clearance Market by Application, Method, Detection and End User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.3 MARKET SHARE ESTIMATION 24
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 25
2.3.3 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 31
4.1 GLOBAL VIRAL CLEARANCE MARKET OVERVIEW 31
4.2 LIFE CYCLE ANALYSIS, BY REGION 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.1.1 MARKET SEGMENTATION, BY APPLICATION 36
5.1.2 MARKET SEGMENTATION, BY END USER 36
5.1.3 MARKET SEGMENTATION, BY METHOD 37
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Rapid growth in pharmaceutical and biotechnology industries 39
5.2.1.2 Increasing number of new drug launches 39
5.2.1.3 Strong trend of RandD investments in the life sciences industry 40
5.2.1.4 Increasing government support for pharmaceutical and biotechnology industries 40
5.2.1.5 High incidence and large economic burden of chronic diseases 41

5.2.2 RESTRAINTS 42
5.2.2.1 High degree of consolidation to act as a major barrier for new entrants 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Increasing pharmaceutical outsourcing 42
5.2.3.2 Developing countries present significant opportunities for the viral clearance market 43
5.2.4 CHALLENGES 43
5.2.4.1 Stringent regulatory frameworks and time-consuming approval processes 43
6 VIRAL CLEARANCE MARKET, BY APPLICATION 44
6.1 INTRODUCTION 45
6.2 VACCINES AND THERAPEUTICS 46
6.3 BLOOD AND BLOOD PRODUCTS 48
6.4 CELLULAR AND GENE THERAPY PRODUCTS 49
6.5 TISSUE AND TISSUE PRODUCTS 51
6.6 STEM CELL PRODUCTS 52
7 VIRAL CLEARANCE MARKET, BY END USER 54
7.1 INTRODUCTION 55
7.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 57
7.3 CONTRACT RESEARCH ORGANIZATIONS 58
7.4 ACADEMIC RESEARCH INSTITUTES 60
7.5 OTHER END USERS 61
8 VIRAL CLEARANCE MARKET, BY METHOD 63
8.1 INTRODUCTION 64
8.2 VIRAL DETECTION METHOD 66
8.2.1 PLAQUE ASSAYS 68
8.2.2 PCR 69
8.2.3 ELISA 70
8.2.4 OTHER VIRAL DETECTION METHODS 71
8.3 VIRAL REMOVAL 74
8.3.1 CHROMATOGRAPHY 76
8.3.2 NANOFILTRATION 77
8.3.3 PRECIPITATION 78
8.4 VIRAL INACTIVATION 80
8.4.1 SOLVENT DETERGENT METHOD 82
8.4.2 PASTEURIZATION 83
8.4.3 OTHER METHODS 84

9 VIRAL CLEARANCE MARKET, BY REGION 86
9.1 INTRODUCTION 87
9.2 NORTH AMERICA 90
9.2.1 U.S. 99
9.2.2 CANADA 102
9.3 EUROPE 105
9.4 ASIA 112
9.5 REST OF THE WORLD 120
10 COMPETITIVE LANDSCAPE 126
10.1 OVERVIEW 126
10.1.1 STRATEGIC OVERVIEW 126
10.2 LEADING PLAYERS IN THE VIRAL CLEARANCE MARKET 127
10.3 COMPETITIVE SITUATION AND TRENDS 129
10.3.1 EXPANSIONS 130
10.3.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 131
10.3.3 ACQUISITIONS 132
10.3.4 SERVICES LAUNCHES 133
11 COMPANY PROFILES 134
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 134
11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 135
11.3 LONZA GROUP 138
11.4 SIGMA-ALDRICH CORPORATION 141
11.5 SGS S.A. 144
11.6 WUXI PHARMATECH (CAYMAN) INC. 146
11.7 AVANCE BIOSCIENCES INC. 149
11.8 BSL BIOSERVICE 150
11.9 CLEAN CELLS INC. 151
11.10 MERCK KGAA 152
11.11 TEXCELL, INC. 155
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.


12 APPENDIX 156
12.1 INSIGHTS OF INDUSTRY EXPERTS 156
12.2 DISCUSSION GUIDE 157
12.3 OTHER DEVELOPMENTS 159
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 161
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 163
12.6 AVAILABLE CUSTOMIZATIONS 164
12.7 RELATED REPORTS 165


LIST OF TABLES

TABLE 1 VIRAL CLEARANCE MARKET SUMMARY 27
TABLE 2 RAPID GROWTH IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES DRIVING THE GROWTH OF THE VIRAL CLEARANCE MARKET 41
TABLE 3 HIGH DEGREE OF CONSOLIDATION IS A MAJOR MARKET RESTRAINT 42
TABLE 4 INCREASING PHARMACEUTICAL OUTSOURCING TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE VIRAL CLEARANCE MARKET 43
TABLE 5 STRINGENT REGULATORY FRAMEWORKS ARE A MAJOR MARKET CHALLENGE 43
TABLE 6 VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 46
TABLE 7 VIRAL CLEARANCE MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013-2020 (USD MILLION) 47
TABLE 8 VIRAL CLEARANCE MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 49
TABLE 9 VIRAL CLEARANCE MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 50
TABLE 10 VIRAL CLEARANCE MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 51
TABLE 11 VIRAL CLEARANCE MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 12 VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 56
TABLE 13 VIRAL CLEARANCE MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 14 VIRAL CLEARANCE MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2013-2020 (USD MILLION) 59
TABLE 15 VIRAL CLEARANCE MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2013-2020 (USD MILLION) 60
TABLE 16 VIRAL CLEARANCE MARKET SIZE FOR OTHER END USERS, BY REGION,
2013-2020 (USD MILLION) 62
TABLE 17 VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION) 65
TABLE 18 VIRAL CLEARANCE MARKET SIZE FOR VIRAL DETECTION, BY METHOD,
2013-2020 (USD MILLION) 66
TABLE 19 VIRAL CLEARANCE MARKET SIZE FOR VIRAL DETECTION, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 20 VIRAL DETECTION MARKET SIZE FOR PLAQUE ASSAYS, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 21 VIRAL DETECTION MARKET SIZE FOR PCR, BY REGION, 2013-2020 (USD MILLION) 70
TABLE 22 VIRAL DETECTION MARKET SIZE FOR ELISA, BY REGION,
2013-2020 (USD MILLION) 71
TABLE 23 VIRAL DETECTION MARKET SIZE FOR OTHER METHODS, BY REGION,
2013-2020 (USD MILLION) 73
TABLE 24 VIRAL CLEARANCE MARKET SIZE FOR VIRAL REMOVAL, BY METHOD,
2013-2020 (USD MILLION) 74
TABLE 25 VIRAL CLEARANCE MARKET SIZE FOR VIRAL REMOVAL, BY REGION,
2013-2020 (USD MILLION) 75
TABLE 26 VIRAL REMOVAL MARKET SIZE FOR CHROMATOGRAPHY, BY REGION,
2013-2020 (USD MILLION) 76
TABLE 27 VIRAL REMOVAL MARKET SIZE FOR NANOFILTRATION, BY REGION,
2013-2020 (USD MILLION) 78
TABLE 28 VIRAL REMOVAL MARKET SIZE FOR PRECIPITATION, BY REGION,
2013-2020 (USD MILLION) 79
TABLE 29 VIRAL CLEARANCE MARKET SIZE FOR VIRAL INACTIVATION, BY METHOD,
2013-2020 (USD MILLION) 80
TABLE 30 VIRAL CLEARANCE MARKET SIZE FOR VIRAL INACTIVATION, BY REGION,
2013-2020 (USD MILLION) 81
TABLE 31 VIRAL INACTIVATION MARKET SIZE FOR SOLVENT DETERGENT METHOD,
BY REGION, 2013-2020 (USD MILLION) 82
TABLE 32 VIRAL INACTIVATION MARKET SIZE FOR PASTEURIZATION, BY REGION,
2013-2020 (USD MILLION) 84
TABLE 33 VIRAL INACTIVATION MARKET SIZE FOR OTHER METHODS, BY REGION,
2013-2020 (USD MILLION) 85
TABLE 34 VIRAL CLEARANCE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 88
TABLE 35 NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 92
TABLE 36 NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 93
TABLE 37 NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 94
TABLE 38 NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY METHOD,
2013-2020 (USD MILLION) 95
TABLE 39 NORTH AMERICA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 96
TABLE 40 NORTH AMERICA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 97
TABLE 41 NORTH AMERICA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 98
TABLE 42 U.S.: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 99
TABLE 43 U.S.: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 100
TABLE 44 U.S.: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION) 100
TABLE 45 U.S.: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 100
TABLE 46 U.S.: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 101
TABLE 47 U.S.: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 101
TABLE 48 CANADA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 102
TABLE 49 CANADA: VIRAL CLEARANCE MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 103
TABLE 50 CANADA: VIRAL CLEARANCE MARKET SIZE, BY METHOD,
2013-2020 (USD MILLION) 103
TABLE 51 CANADA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 103
TABLE 52 CANADA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 104
TABLE 53 CANADA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 104
TABLE 54 EUROPE: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 106
TABLE 55 EUROPE: VIRAL CLEARANCE MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 107
TABLE 56 EUROPE: VIRAL CLEARANCE MARKET SIZE, BY METHOD,
2013-2020 (USD MILLION) 108
TABLE 57 EUROPE: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 109
TABLE 58 EUROPE: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 110
TABLE 59 EUROPE: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 111
TABLE 60 ASIA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 114
TABLE 61 ASIA: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 115
TABLE 62 ASIA: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION) 116
TABLE 63 ASIA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 117
TABLE 64 ASIA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 118
TABLE 65 ASIA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 119
TABLE 66 ROW: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 121
TABLE 67 ROW: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 122
TABLE 68 ROW: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION) 123
TABLE 69 ROW: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 123
TABLE 70 ROW: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 124
TABLE 71 ROW: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 125
TABLE 72 MARKET DEVELOPMENTS BETWEEN 2012 AND 2016 129
TABLE 73 EXPANSIONS, 2012-2016 130
TABLE 74 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2016 131
TABLE 75 ACQUISITIONS, 2012-2016 132
TABLE 76 SERVICES LAUNCHES, 2012-2015 133


LIST OF FIGURES

FIGURE 1 GLOBAL VIRAL CLEARANCE MARKET 17
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION) 28
FIGURE 8 VIRAL CLEARANCE MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 29
FIGURE 9 VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2015 VS. 2020 (USD MILLION) 29
FIGURE 10 VIRAL CLEARANCE MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 30
FIGURE 11 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES WILL DRIVE THE VIRAL CLEARANCE MARKET IN THE FORCASTED PERIOD (2015-2020) 31
FIGURE 12 VACCINES AND THERAPEUTICS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 32
FIGURE 13 ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
(2015 TO 2020) 33
FIGURE 14 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 34
FIGURE 15 VIRAL CLEARANCE MARKET SEGMENTATION, BY APPLICATION 36
FIGURE 16 VIRAL CLEARANCE MARKET SEGMENTATION, BY END USER 36
FIGURE 17 VIRAL CLEARANCE MARKET SEGMENTATION, BY METHOD 37
FIGURE 18 VIRAL CLEARANCE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, and CHALLENGES 38
FIGURE 19 NUMBER OF NEW BIOLOGICS LAUNCHED, BY YEAR, 2003-2013 40
FIGURE 20 VIRAL CLEARANCE MARKET, BY APPLICATION 45
FIGURE 21 VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2015 (USD MILLION) 45
FIGURE 22 NORTH AMERICA TO DOMINATE THE VACCINES AND THERAPEUTICS APPLICATION SEGMENT IN 2015 47
FIGURE 23 NORTH AMERICA TO DOMINATE THE BLOOD AND BLOOD PRODUCTS APPLICATION SEGMENT IN 2015 48
FIGURE 24 ASIA TO WITNESS HIGHEST GROWTH IN THE CELLULAR AND GENE THERAPY PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD 50
FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE TISSUE AND TISSUE PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD 51
FIGURE 26 ASIA TO WITNESS HIGHEST GROWTH IN THE STEM CELL PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD 52
FIGURE 27 VIRAL CLEARANCE MARKET, BY END USER 55
FIGURE 28 VIRAL CLEARANCE MARKET SIZE, BY END USER, 2015 (USD MILLION) 56
FIGURE 29 NORTH AMERICA TO DOMINATE THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES END-USER SEGMENT DURING THE FORECAST PERIOD 57
FIGURE 30 ASIA TO WITNESS THE HIGHEST GROWTH IN THE CONTRACT RESEARCH ORGANIZATIONS END-USER SEGMENT DURING THE FORECAST PERIOD 59
FIGURE 31 ASIA TO WITNESS THE HIGHEST GROWTH IN THE ACADEMIC RESEARCH INSTITUTES END-USER SEGMENT DURING THE FORECAST PERIOD 60
FIGURE 32 NORTH AMERICA TO DOMINATE THE OTHER END-USERS SEGMENT DURING THE FORECAST PERIOD 62
FIGURE 33 VIRAL CLEARANCE MARKET, BY METHOD 64
FIGURE 34 VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2015 (USD MILLION) 65
FIGURE 35 PLAQUE ASSAYS TO DOMINATE THE VIRAL DETECTION METHOD SEGMENT IN 2015 66
FIGURE 36 NORTH AMERICA TO DOMINATE THE VIRAL DETECTION MARKET IN 2015 67
FIGURE 37 NORTH AMERICA TO DOMINATE THE PLAQUE ASSAYS METHOD SEGMENT IN 2015 68
FIGURE 38 NORTH AMERICA TO DOMINATE THE PCR MARKET IN 2015 69
FIGURE 39 NORTH AMERICA TO DOMINATE THE MARKET FOR ELISA METHOD IN 2015 70
FIGURE 40 NORTH AMERICA TO DOMINATE THE MARKET FOR OTHER VIRAL DETECTION METHODS IN 2015 73
FIGURE 41 CHROMATOGRAPHY TO DOMINATE THE VIRAL REMOVAL METHODS SEGMENT
IN 2015 74
FIGURE 42 NORTH AMERICA TO DOMINATE THE VIRAL REMOVAL MARKET IN 2015 75
FIGURE 43 NORTH AMERICA TO DOMINATE THE CHROMATOGRAPHY MARKET IN 2015 76
FIGURE 44 NORTH AMERICA TO COMMAND LARGEST SHARE IN THE NANOFILTRATION SEGMENT IN 2015 77
FIGURE 45 NORTH AMERICA TO HOLD LARGEST SHARE OF THE PRECIPITATION MARKET
IN 2015 79
FIGURE 46 SOLVENT DETERGENT METHOD TO HOLD LARGEST SHARE IN VIRAL INACTIVATION MARKET IN 2015 80
FIGURE 47 NORTH AMERICA TO DOMINATE THE VIRAL INACTIVATION MARKET IN 2015 81
FIGURE 48 NORTH AMERICA TO DOMINATE THE SOLVENT DETERGENT METHOD SEGMENT
IN 2015 82
FIGURE 49 NORTH AMERICA TO DOMINATE THE PASTEURIZATION SEGMENT IN 2015 83
FIGURE 50 NORTH AMERICA TO DOMINATE THE OTHER VIRAL INACTIVATION METHODS SEGMENT IN 2015 84
FIGURE 51 VIRAL CLEARANCE MARKET SEGMENTATION, BY REGION 87
FIGURE 52 NORTH AMERICA TO DOMINATE THE GLOBAL VIRAL CLEARANCE MARKET DURING THE FORECAST PERIOD 88
FIGURE 53 ASIAN VIRAL CLEARANCE MARKET TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020 89
FIGURE 54 NORTH AMERICA: VIRAL CLEARANCE MARKET SNAPSHOT 91
FIGURE 55 U.S. TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN VIRAL CLEARANCE MARKET 92
FIGURE 56 VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE NORTH AMERICAN VIRAL CLEARANCE MARKET 93
FIGURE 57 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE NORTH AMERICAN VIRAL CLEARANCE MARKET, BY END USER 94
FIGURE 58 VIRAL DETECTION, THE LARGEST METHOD SEGMENT IN NORTH AMERICA IN 2015 95
FIGURE 59 PLAQUE ASSAYS SEGMENT TO HOLD LARGEST SHARE OF THE NORTH AMERICAN VIRAL DETECTION MARKET IN 2015 96
FIGURE 60 CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN NORTH AMERICA IN 2015 97
FIGURE 61 SOLVENT DETERGENT SEGMENT TO DOMINATE THE VIRAL INACTIVATION MARKET, BY METHOD, IN NORTH AMERICA 98
FIGURE 62 VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE EUROPEAN VIRAL CLEARANCE MARKET 106
FIGURE 63 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE EUROPEAN VIRAL CLEARANCE MARKET 107
FIGURE 64 VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN EUROPE IN 2015 108
FIGURE 65 PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN EUROPE IN 2015 109
FIGURE 66 CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN EUROPE IN 2015 110
FIGURE 67 SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN EUROPE IN 2015 111
FIGURE 68 ASIA: VIRAL CLEARANCE MARKET SNAPSHOT 113
FIGURE 69 VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE ASIAN VIRAL CLEARANCE MARKET 114
FIGURE 70 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE ASIAN VIRAL CLEARANCE MARKET 115
FIGURE 71 VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN ASIA IN 2015 116
FIGURE 72 PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN ASIA IN 2015 117
FIGURE 73 CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN ASIA IN 2015 118
FIGURE 74 SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN ASIA IN 2015 119
FIGURE 75 VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE VIRAL CLEARANCE MARKET IN THE REST OF THE WORLD REGION 120
FIGURE 76 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRAL CLEARANCE MARKET IN THE REST OF THE WORLD REGION 121
FIGURE 77 VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN THE REST OF THE WORLD REGION IN 2015 122
FIGURE 78 PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015 123
FIGURE 79 CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015 124
FIGURE 80 SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015 125
FIGURE 81 EXPANSIONS AND ACQUISITIONS—KEY STRATEGIES ADOPTED BY PLAYERS 126
FIGURE 82 VIRAL CLEARANCE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 127
FIGURE 83 FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS 134
FIGURE 84 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 135
FIGURE 85 COMPANY SNAPSHOT: LONZA GROUP 138
FIGURE 86 COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION 141
FIGURE 87 COMPANY SNAPSHOT: SGS S.A. 144
FIGURE 88 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC. 146
FIGURE 89 COMPANY SNAPSHOT: MERCK and CO., INC. 152

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

This report on the white biotechnology market studies the current as well as future prospects of the market globally. Environment concerns related to emission of greenhouse gases and dependence on non-renewable ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.